Helixgate https://validator.w3.org/feed/docs/rss2.html Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns Kennedy posts vaccine misinformation, spars on social media amid measles deaths Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular Damage Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA Spyre tumbles as immune drug misses mark in rheumatoid arthritis RevMed receives early FDA approval for ‘groundbreaking’ pancreatic cancer drug Summit, Akeso tout biliary cancer win for PD-1/VEGF in China—but details are pending BMS ends Cellares pact over cell therapy production problems, triggering layoffs Biohaven could get up to $795M in epilepsy alliance with SK Bio 2026 IPO stock tracker: How newly public biotechs are performing Jazz scores front-line gastric cancer nod from FDA for ‘practice-changing’ Ziihera Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealed CDMO hiring tough as demand for specialized talent outpaces supply Inside the Gulf biotech deal model, ahead of RGMBS 2026 in Riyadh New Jazz cancer drug approval could drive blockbuster sales STAT+: Sword Health to acquire Headspace, according to filing In Massachusetts, Latest Annual Snapshot Shows a Tale of Two Biopharmas Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test Pennsylvania reports first 2 measles deaths in the U.S. this year, both people unvaccinated Expanded Synthetic Promoter Library Introduced to Boost Biomanufacturing Operations STAT+: How Trump’s funding cuts are reshaping the health system Biotech IPOs approach ‘escape velocity’ barring yellow flags that could threaten rebound China’s Haisco forms immunology biotech with up to $1.5B from American VCs New drug displays anti-inflammatory and neuroprotective effects in ALS Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail Labcorp launches new hepatitis D test to find patients with most severe form of virus Lilly takes oral obesity race abroad with UK launch of Foundayo Massachusetts biopharma jobs, including R&D positions, fell in 2025: Report NASA finds Earth microbes could survive on the Moon Preparing for Novartis showdown, Curium touts value of radiopharma supply resiliency Young startups miss out on biotech venture funding rebound, MassBio says Predictive design of tissue-specific mammalian enhancers that function in the mouse embryo Transferable genetic toolsets for nonmodel gut Clostridia enable in vivo reversible control of metabolite production Helixgate AI & Biotech Collaboration Series + Helixgate Industry Nights Home PARP Inhibitor Combination Therapy Boosts Antitumor Activity in NSCLC Models DC judge rejects Merck’s IRA case more than three years after it was filed Safety concerns spur FDA to again halt testing of Regenxbio gene therapy FDA extends review of Capricor cell therapy; Pain drug startup to go public Capricor’s Duchenne therapy has new life after FDA grants 3-month extension Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development Cellares, a cell therapy manufacturing specialist, to lay off 100 employees Fibrinogen discovery reshapes our understanding of how wounds heal STAT+: Lady Gaga and her fiancé launch a biotech startup REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drug FDA plans to regulate generative AI Kennedy questions vaccination guidelines following Trump’s order to break up MMR Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’